Buy Imatib 100 mg (10 Tablets) Imatinib Online
Imatib Imatinib – 100 mg (1 pack / 10 tablets)
At a Glance
Brand name: Imatib
Generic name: Imatinib mesylate
Active ingredient: Imatinib
Strength & pack size: Imatib 100 mg (1 pack / 10 tablets)
Dosage form: Oral film-coated tablets
Main indication: Philadelphia chromosome–positive chronic myeloid leukemia (CML) and selected gastrointestinal stromal tumors (GIST)
Therapeutic class: Tyrosine kinase inhibitor (TKI)
Use in therapy: Targeted systemic treatment for Ph+ CML and indicated solid tumors
Prescription status: Prescription-only anticancer medicine
Supplied by: Licensed manufacturers and authorised distributors
Storage: Store below 25 °C in a dry place, protected from moisture and light
Product Description
Imatib 100 mg tablets are a generic imatinib mesylate medicine used in the treatment of specific blood cancers and solid tumors.
Imatinib is a well-known tyrosine kinase inhibitor (TKI) that has transformed outcomes for patients with
Philadelphia chromosome–positive chronic myeloid leukemia (CML) and certain gastrointestinal stromal tumors (GIST).
Imatib 100 mg (1 pack / 10 tablets) offers a compact pack size that may be used as an initial supply, a short bridging course or as continuation therapy,
always according to your specialist’s prescription.
Each Imatib tablet contains 100 mg of imatinib, taken by mouth, usually once or twice daily depending on the required total daily dose.
The 100 mg strength provides flexibility for dose titration and individualised treatment regimens. Because
Imatib is a generic imatinib product, it contains the same active ingredient as branded imatinib while offering a more accessible price in USD,
which can be important for patients who need long-term imatinib therapy.
When you buy Imatib 100 mg online from Generic Meds Mart, you receive imatinib tablets supplied by licensed manufacturers and authorised distributors
that follow recognised GMP standards. The medicine is shipped in plain, discreet outer packaging, while original blisters and cartons maintain full details such as strength, batch number and expiry date.
This Imatib 100 mg (1 pack / 10 tablets) product is intended only for patients already under the care of a haematologist or oncologist who has recommended
imatinib tablets as part of a treatment plan. Generic Meds Mart does not diagnose conditions or change treatment protocols;
the information on this page is designed to support informed discussions with your specialist about access to generic imatinib.
Key Uses
Imatib 100 mg imatinib tablets are typically used for the following indications under specialist supervision:
- Treatment of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in chronic, accelerated or blast phase as directed
- Treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) in selected patients
- Treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) expressing KIT (CD117) or other relevant targets
- Treatment of other rare malignancies where imatinib is specifically recommended in recognised oncology guidelines
Your specialist will determine how Imatib 100 mg fits into your therapy, what total daily dose you need and how long
imatinib treatment should continue.
How Imatinib Works in Chemotherapy
Imatinib is a targeted anticancer agent often grouped within modern systemic chemotherapy and targeted therapy regimens.
Imatib 100 mg contains imatinib, a tyrosine kinase inhibitor (TKI) that blocks abnormal signalling from specific tyrosine kinases such as BCR-ABL in CML
and KIT in many GIST tumours.
Imatib imatinib tablets work by binding to these overactive kinases and blocking their ATP-binding sites.
This disrupts the signalling pathways that drive uncontrolled cancer cell growth and survival. In
chronic myeloid leukemia, this targeted inhibition can reduce leukemic cell counts and support long-term disease control.
In GIST, inhibition of KIT may shrink or stabilise tumours that depend on this pathway.
Because imatinib acts as a targeted TKI rather than a traditional cytotoxic drug, its side effect profile differs from standard chemotherapy.
However, Imatib 100 mg is still a potent anticancer medicine that must be monitored carefully by an experienced haematologist or oncologist.
Dosage & Administration
Imatib 100 mg imatinib tablets must always be taken exactly as prescribed by your specialist.
Daily dosing, timing and duration of therapy depend on your diagnosis, disease phase, response and tolerance.
- Take Imatib tablets by mouth with a large glass of water; many patients are advised to take doses with food to reduce stomach discomfort.
- Swallow the tablets whole. Do not crush, split or chew Imatib 100 mg tablets unless your doctor or pharmacist has given specific instructions.
- The total daily dose may be taken once daily or divided into two doses, depending on your prescription and how well you tolerate treatment.
- Do not change your dose or stop taking Imatib without clear instructions from your haematologist or oncologist.
- If you miss a dose, follow your doctor’s advice; do not double the next dose to compensate unless your specialist has recommended it.
Your oncology team will schedule regular blood tests and other assessments to monitor your response to
Imatib imatinib therapy and to guide any necessary dose adjustments.
Precautions
Before starting Imatib 100 mg, inform your doctor about your full medical history and all medicines, supplements or herbal products you use. Important considerations include:
- History of liver disease, kidney impairment or significant cardiac disease
- Pre-existing fluid retention, swelling, heart failure or shortness of breath
- Previous or current gastrointestinal bleeding, ulcers or serious stomach or bowel conditions
- Use of other anticancer medicines, immunosuppressants or biologic therapies
- Use of strong CYP3A4 inhibitors or inducers, certain antibiotics, antifungals or antiepileptics that may interact with imatinib
- Use of paracetamol, anticoagulants or other medicines that may require careful monitoring with Imatib imatinib tablets
Imatinib may not be suitable during pregnancy, and effective contraception is usually recommended during treatment and for a period afterwards, as advised by your doctor.
Breastfeeding is often discouraged while taking Imatib. Your specialist will set an appropriate monitoring schedule in your case.
Imatinib Side Effects
Common side effects
Many patients experience side effects when starting Imatib imatinib tablets, especially during the first months of treatment. Common reactions may include:
- Nausea, mild vomiting or stomach discomfort
- Diarrhea or, in some cases, constipation
- Fluid retention with swelling of ankles, legs or around the eyes
- Muscle cramps, bone pain or joint discomfort
- Fatigue, weakness or general tiredness
- Mild skin rash or itching
These side effects are often manageable with supportive care or dose adjustments, but you should report persistent or troublesome symptoms to your oncology team.
Serious side effects
Some side effects of imatinib are less common but more serious and require urgent medical attention. Serious reactions may include:
- Marked fluid retention with sudden weight gain, worsening shortness of breath or pronounced leg swelling
- Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
- Severe abdominal pain, bloody stools or vomiting blood, which may indicate serious gastrointestinal issues
- Significant changes in blood counts, with fever, frequent infections, unusual bruising or prolonged bleeding
- Severe skin reactions, widespread rash, blistering or involvement of the mouth or eyes
If you experience any of these serious symptoms while taking Imatib 100 mg, seek immediate medical care and contact your specialist as soon as possible.
Storage
- Store Imatib 100 mg tablets at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
- Keep the tablets in their original blisters and carton until use to protect them from moisture and light.
- Keep Imatib imatinib tablets out of the sight and reach of children and pets.
- Do not use the medicine after the expiry date printed on the packaging.
Ask your pharmacist or follow local regulations for safe disposal of unused or expired imatinib tablets.
Why Buy from Generic Meds Mart
Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Imatib 100 mg imatinib tablets at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.
When you buy Imatib 100 mg online from Generic Meds Mart, you benefit from:
- Competitive pricing on generic imatinib tablets compared with many local pharmacies
- Discreet, plain packaging designed to protect your privacy during shipping
- Tracked international delivery options to many destinations
- Clear, structured product information to support discussions with your haematologist or oncologist
- Customer support available to assist with ordering, payment and shipping questions
Our goal is to help you maintain continuity of prescribed targeted therapy with transparent conditions and professional handling of each order.
Order Now
Imatib 100 mg imatinib tablets are prescription-only anticancer medicines and must be used strictly under the supervision of a haematologist or oncologist.
Before you order Imatib 100 mg online, ensure that you have a valid prescription or written treatment plan specifying imatinib, the required daily dose and intended duration of therapy.
Select Imatib 100 mg (1 pack / 10 tablets), choose the appropriate quantity, add Imatib to your cart and complete the secure checkout process.
Your order will be processed, packed discreetly and shipped with tracking where available.
Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your oncology team.



Reviews
There are no reviews yet.